Younger adults hit hardest by pandemic-related anxiety and depression

A JAMA Network Open study reveals age-related disparities in anxiety and depression among U.S. adults during the COVID-19 pandemic, with younger adults (18-39 years) experiencing higher levels of these mental health issues.

Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy

Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting

May 23, 2024

EU’s pharma legislative reforms ‘will scare investment away,’ Astellas executive says

Europe is on the brink of wrapping up its first major legal and regulatory reforms for the pharma industry in about two decades, but some

April 2, 2024

For biotechs in the industry’s handful of hot areas, it’s a seller’s market

A radiopharma company purchased for more than three times the price of its IPO from a few months earlier. Neuroscience companies driving up their offers

January 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.